Form 4: Encompass Health Corp: CEO Mark J. Tarr Acquires Stock Options

Encompass Health Corp's CEO, Mark J. Tarr, acquired 33,086 non-qualified stock options on March 4, 2025, exercisable in installments starting March 4, 2026.

Summary

• Mark J. Tarr, the President & CEO of Encompass Health Corp, filed a Form 4 on March 5, 2025.
• The filing reports a transaction that occurred on March 4, 2025, where Tarr acquired 33,086 non-qualified stock options.
• The exercise price of these options is $98.45.
• The options become exercisable in equal annual installments over a three-year period commencing March 4, 2026.
• The options expire on March 4, 2035.
• Following the reported transaction, Tarr directly owns 33,086 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects a standard executive compensation practice. The acquisition of stock options is generally viewed as a positive sign, aligning management's interests with shareholders, but it's a routine event.

Positives

• The acquisition of stock options by the CEO could align his interests more closely with those of the shareholders.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the options.

Industry Context

This filing is a routine disclosure related to executive compensation and is common in publicly traded companies. It reflects part of the company's incentive structure for its top executives.

Stakeholder Impact

• The acquisition of stock options by the CEO could potentially align his interests more closely with those of the shareholders, incentivizing him to increase shareholder value.

Key Dates